Voyageur Pharmaceuticals (CVE:VM) Trading 47.4% Higher – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price traded up 47.4% during trading on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during mid-day trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a fifty day moving average of C$0.08 and a two-hundred day moving average of C$0.06.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.